What do investors look for in medical device start-ups? What value do they provide to entities like CBID, a biodesign research center and provider of a cutting-edge master’s program in biodesign? To gain more insight into where academia meets bio-innovation, I spoke to Professor Yazdi.
Biochemist and neurobiologist Michael Lin is developing smart biological therapies that may finally provide the “magic bullet” for cancer. He sat down with Probe Magazine to discuss his dreams and current research projects, and give a few words of advice to STEM students.